Open Access 02.05.2024 | Original Research Article
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies
Erschienen in: American Journal of Clinical Dermatology